跳至主要内容
临床试验/NCT04986826
NCT04986826Unknown不适用

Exercise Effect on Transthyretin Stability in Master Athletes and Patients With Transthyretin Amyloidosis

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2021年7月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
24
试验地点
1
主要终点
Change in percent transthyretin stability assay

研究概览

简要总结

The goal of this study to investigate if exercise predisposes to transthyretin instability. The investigators will evaluate the effect of exercise on transthyretin biochemistry.

详细描述

This is an investigator initiated observational study, designed to study the effect of exercise on transthyretin stability in three main populations: Group 1: healthy master athletes who are 60 years or older. Group 2: Genotype positive (G+) cardiac phenotype negative (P-) patients with variant ATTR (i.e. carriers without evidence of disease). Group 3: Patients with ATTR CA who have not been on a stabilizer (tafamidis) within the last 14 days prior to enrollment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • General inclusion criteria: patients should be able to exercise on a treadmill or a bike, willing to consent to the study procedures and willing to return to site during the follow up period of 72 hours for repeated blood and urine collection
  • Specific inclusion criteria:
  • Group 1: Subjects must be at least 60 years of age and meet the master athlete definition of: athletes engaged in cycling ≥8 hours per week or running ≥6 hours per week or triathlon training (combination of swimming, cycling, running) ≥8 hours per week, or equivalent sports activities, for at least 6 months prior to enrollment.
  • Group 2: Genotype positive (G+) cardiac phenotype negative (P-) patients with variant ATTR (i.e. carriers without evidence of disease)
  • Group 3: Patients with ATTR CA who have not been on a stabilizer (tafamidis) within the last 14 days prior to enrollment.

排除标准

  • Taking diflunisal or daily non-steroidal anti-inflammatory drugs (NSAIDs) use within 2 weeks.

结局指标

主要结局

Change in percent transthyretin stability assay

时间窗: Change from baseline to 72 hours post-exercise

Transthyretin stability will be measured and expressed as a percentage

次要结局

  • Plasma transthyretin fragments(Change from baseline to 72 hours post-exercise)
  • Plasma transthyretin level(Change from baseline to 72 hours post-exercise)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmad Masri

Principal Investigator

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验